Thyrotoxic Periodic Paralysis: Clinical Challenges
Open accessAbstract
Thyrotoxic periodic paralysis (TPP), a disorder most commonly seen in Asian men, is characterized by abrupt onset of hypokalemia and paralysis. The condition primarily affects the lower extremities and is secondary to thyrotoxicosis. The underlying hyperthyroidism is often subtle causing difficulty in early diagnosis. Factors like high-carbohydrate meal exercise, steroid, and stress can precipitate an attack of TPP. Evidence is building up showing role of genetic mutations in Kir2.6 channel in the pathogenesis of TPP. Loss of function of Kir2.6 together with increased activity of Na+/K+ATPase may trigger a positive feed-forward cycle of hypokalemia. Biochemical hyperthyroidism with normal urinary potassium excretion and ECG changes are characteristic of TPP. Treatment with low-dose potassium supplements and nonselective beta-blockers should be initiated upon diagnosis, and the serum potassium level should be frequently monitored to prevent rebound hyperkalemia.
AI snapshot
Written from the paper’s full text.
TL;DR
Thyrotoxic periodic paralysis (TPP) is an acute, hypokalemic paralytic disorder seen predominantly in Asian men with often-subtle hyperthyroidism, driven by increased Na⁺/K⁺-ATPase activity and loss-of-function Kir2.6 channel mutations. This narrative review summarizes its epidemiology, pathophysiology, clinical features, and treatment, emphasizing low-dose potassium plus nonselective beta-blockers and monitoring to avoid rebound hyperkalemia.
Key findings
- TPP incidence in thyrotoxic patients is reported at 1.8% in Chinese and 1.9% in Japanese versus 0.1%–0.2% in North Americans; the male-to-female ratio ranges from 17:1 to 70:1 despite hyperthyroidism being more common in females (9:1 female-to-male).
- Kir2.6 mutations were found in up to 33% of Caucasians and Brazilians with TPP; loss of Kir2.6 function combined with increased Na⁺/K⁺-ATPase activity is proposed to trigger a feed-forward hypokalemia cycle causing paradoxical depolarization and muscle inexcitability.
- In a 10-year study of 135 TPP patients, only 34% had identifiable precipitants (high-carbohydrate meal 12%, strenuous exercise 7%); only 17% had toxic thyrotoxicosis by Wayne's index (score >19).
- Rebound hyperkalemia occurred in approximately 40% of TPP patients, especially with >90 mEq KCl in the first 24 hours; doses ≤50 mEq rarely caused it. Propranolol 40 mg four times daily prevented carbohydrate-induced paralysis in about two thirds of cases, and IV potassium shortened recovery (6.3 vs. 13.5 hours) versus saline.
Methods
- Narrative review (no systematic search strategy, inclusion criteria, or meta-analysis described) synthesizing prior literature on TPP.
- Evidence drawn from cited case series, cohort studies, and mechanistic/genetic studies (47 references), including a 10-year series of 135 patients and reports on Kir2.6 mutations.
- Main analysis is qualitative synthesis of epidemiology, pathophysiology, clinical features, differential diagnosis, and treatment; no primary data collection or statistical analysis reported.
Limitations
- The paper states no explicit limitations.
- Evident from the text: it is a narrative review without a described systematic search or quality appraisal, so selection and reporting of cited studies may be biased; several key figures (e.g., incidence, mutation prevalence, rebound hyperkalemia rate) derive from heterogeneous, often single-center or retrospective sources.
- The text itself notes that the pathogenesis "remains unclear," that standardization of the glucose meal test for diagnosis is unavailable, and that required potassium doses are variable (10–200 mEq), reflecting unresolved diagnostic and therapeutic uncertainty.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 54 cited sources checked · 0 supported · 0 flagged
- Premisecitation
Androgens increase the expression and activity of the Na+/K+-ATPase.
“Androgens have been reported to increase the expression and activity of the Na+/K+-ATPase [11, 12].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisenone given
In familial hypokalemic periodic paralysis, paradoxical depolarization is caused by mutations in the voltage sensor of Nav1.4 and Cav1.1 channels, giving imbalance between inward leak current and outward K current.
“In familial Hypokalemic periodic paralysis paradoxical depolarization is caused by mutations in the voltage sensor of Nav1.4 and Cav1.1 channels giving imbalance between inward leak current and outward K current.”
Quote in the paperNot a substantial claim - Premisecitation
The outward Kir current is decreased in intercostal muscle fibers of both patients with TPP and familial hypokalemic periodic paralysis.
“Studies have shown that the outward Kir current is decreased in intercostal muscle fibers of both patients with TPP and familial hypokalemic periodic paralysis [16].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] source
Not checked in the free run.
- Interpretationreasoning
Patients with TPP have an underlying predisposition for activation of Na/K-ATPase activity, either directly by thyroid hormone or indirectly via adrenergic stimulation, insulin, or exercise.
“Overall, it appears that patients with TPP have an underlying predisposition for activation of Na/K-ATPase activity, either directly by thyroid hormone or indirectly via adrenergic stimulation, insulin, or exercise.”
Quote in the paperSubstantial claim - Premisenone given
Thyroid hormone upregulates the transcription of Kir2.6 through an upstream thyroid hormone responsive element in the promoter region of the channel gene.
“Thyroid hormone upregulates the transcription of Kir2.6 through an upstream thyroid hormone responsive element in the promoter region of channel gene.”
Quote in the paperNot a substantial claim
- Premisereasoning
Central to the pathophysiology of skeletal muscle paralysis in hypokalemic periodic paralysis is paradoxical depolarization.
“The central to pathophysiology of skeletal muscle paralysis in hypokalemic periodic paralysis is paradoxical depolarization.”
Quote in the paperSubstantial claim - Premisecitation
The total intracellular potassium content measured in the diaphragm muscle of a thyrotoxic mouse is unchanged from the normal.
“It was seen that the total intracellular potassium content measured in the diaphragm muscle of a thyrotoxic mouse is unchanged from the normal [15].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] 1986, Pflügers Archiv source
Not checked in the free run.
- Premisecitation
The prevalence of Kir2.6 mutation was up to 33% in Caucasians and Brazilians with TPP.
“A study by Ryan et al. [18] showed that the prevalence of Kir2.6 mutation was up to 33% in Caucasians and Brazilians with TPP.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] source
Not checked in the free run.
- Premisecitation
The underlying hyperthyroidism in TPP is often subtle, causing difficulty in early diagnosis.
“The underlying hyperthyroidism is often subtle causing difficulty in early diagnosis.”
- Also stated in: § 7. Conclusion · plain
“The subtleness of underlying hyperthyroidism often delays diagnosis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] 1996, QJM source
Not checked in the free run.
- Also stated in: § 7. Conclusion · plain
- Interpretationreasoning
The enhanced beta-adrenergic response in thyrotoxicosis further increases Na+/K+-ATPase activity.
“The enhanced beta-adrenergic response in thyrotoxicosis further increases Na+/K+-ATPase activity.”
Quote in the paperSubstantial claim - Interpretationreasoning
Activation of Na+/K+ ATPase cannot be the only mechanism for TPP.
“Activation of Na+/K+ ATPase cannot be the only mechanism for TPP, because only a minority (∼2%) of patients with hyperthyroidism develop hypokalemic paralysis.”
Quote in the paperSubstantial claim- Rests on an assumption: Only a minority (about 2%) of patients with hyperthyroidism develop hypokalemic paralysis.
- Interpretationreasoning
Hypokalemia-induced paradoxical depolarization of the resting membrane potential leads to inactivation of Na+ channels, rendering them unexcitable.
“This hypokalemia-induced paradoxical depolarization of the resting membrane potential leads to inactivation of Na+ channels, rendering them unexcitable.”
Quote in the paperSubstantial claim - Interpretationcitation
Insulin participates in the pathogenesis of hypokalemia in TPP.
“Hyperinsulinemia is also observed in acute attack of TPP, and the release of insulin in response to oral glucose challenge is exaggerated in TPP patients, supporting the idea that insulin participates in the pathogenesis of hypokalemia in TPP [9].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] source
Not checked in the free run.
- Premisecitation
Catecholamine can increase Na+/K+-ATPase activity in skeletal muscle.
“Catecholamine can also increase Na+/K+-ATPase activity in skeletal muscle [8].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] 1982, Annals of Neurology source
Not checked in the free run.
- Premisecitation
The activity of Na+-K+ ATPase pumps in skeletal muscle is significantly increased in TPP.
“The important role of Na+-K+ ATPase pumps in the pathogenesis of TPP is supported by the finding that their activity in the skeletal muscle is significantly increased.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] 1991, The British Medical Journal source
Not checked in the free run.
- Interpretationcitation
Loss of function of Kir2.6 together with increased activity of Na+/K+ ATPase may trigger a positive feed-forward cycle of hypokalemia.
“Loss of function of Kir2.6 together with increased activity of Na+/K+ ATPase may trigger a positive feed-forward cycle of hypokalemia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] source
Not checked in the free run.
- Premisecitation
Catecholamines are released more in males in response to experimental stress.
“Catecholamines, a strong activator of Na+/K+-ATPase activity, have been found to be released more in males in response to experimental stress [13].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [13] source
Not checked in the free run.
- Premisecitation
Thyrotoxic patients with periodic paralysis have higher sodium pump activity than those without paralytic episodes.
“Thyrotoxic patients with PP have been found to have higher sodium pump activity than those without paralytic episodes [7].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] 1991, The British Medical Journal source
Not checked in the free run.
- Premisecitation
Insulin stimulates Na+/K+-ATPase activity.
“Insulin-response sequences are present in the upstream region of Na+/K+-ATPase genes, and insulin has been shown to stimulate Na+/K+-ATPase activity [10].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] 1994, Clinical Endocrinology source
Not checked in the free run.
- Premisecitation
Kir2.6 mutants exert a dominant negative effect on both WT Kir2.1 and Kir2.6 channels.
“Kir2.6 mutants exert a dominant negative effect on both WT Kir2.1 and Kir2.6 channels.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] source
Not checked in the free run.
- Interpretationreasoning
The increased Na-K ATPase activity in muscle may be compensated by increased potassium efflux preventing development of hypokalemia.
“The increased Na-K ATPase activity in muscle may be compensated by increased potassium efflux preventing development of hypokalemia.”
Quote in the paperSubstantial claim - Premisenone given
Muscle fibers from patients with hypokalemic periodic paralysis depolarize under low extracellular K+ concentrations (<3 mEq/L).
“However, muscle fibers from patients with hypokalemic periodic paralysis depolarize under low extracellular K+ concentrations (<3 mEq/L).”
Quote in the paperNot a substantial claim - Premisenone given
The attack of TPP is characterized by recurrent, transient episodes of muscle weakness that range from mild weakness to complete flaccid paralysis.
“The attack is characterized by recurrent, transient episodes of muscle weakness that range from mild weakness to complete flaccid paralysis.”
Quote in the paperNot a substantial claim - Premisecitation
Cheng et al. found three additional loss-of-function mutations in Kir2.6 channels in patients with TPP as well as sporadic periodic paralysis.
“Cheng et al. [19] found three additional loss-of-function mutations in Kir2.6 channels in patients with TPP as well as sporadic periodic paralysis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] source
Not checked in the free run.
- Interpretationcitation
Genetic mutations in the Kir2.6 channel play a role in the pathogenesis of TPP.
“Evidence is building up showing role of genetic mutations in Kir2.6 channel in the pathogenesis of TPP.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationcitation
The preponderance of TPP attacks in the morning may stem from higher plasma catecholamines and sympathetic tone in the late morning.
“The preponderance of TPP attacks in the morning may also stem from higher plasma catechol-amines and sympathetic tone in the late morning [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] source
Not checked in the free run.
- Interpretationreasoning
The effect of insulin may account for the observation that a high-carbohydrate diet can be a precipitating factor for TPP.
“The effect of insulin may account for the observation that a high-carbohydrate diet can be a precipitating factor for TPP.”
Quote in the paperNot a substantial claim - Premisecitation
One prospective study compared treatment with intravenous potassium chloride to normal saline infusion and found a shorter recovery time with use of potassium (6.3 vs. 13.5 hours).
“One prospective study compared treatment with intravenous potassium chloride to normal saline infusion and found a shorter recovery time with use of potassium (6.3 vs. 13.5 hours) [42].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] source
Not checked in the free run.
- Premisecitation
Only 10 of 55 (18%) patients developed hypokalemia after glucose loading of 2 g/Kg.
“It was found that only 10 of the 55 (18%) patients developed hypokalemia after glucose loading of 2 g/Kg.”
Quote in the paperNot a substantial claim - Premisecitation
In a recent study, none of the 51 cases of TPP developed symptoms after glucose loading test.
“Also in a recent study none of the 51 cases of TPP developed symptoms after glucose loading test [25].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] source
Not checked in the free run.
- Premisereasoning
Patients receiving a total dose of ≤50 mEq of potassium chloride rarely develop rebound hyperkalemia.
“Patients receiving a total dose of ≤50 mEq of potassium chloride rarely develop rebound hyperkalemia.”
Quote in the paperSubstantial claim - Premisecitation
Only 34% of TPP patients had identifiable precipitants.
“It was found that only 34% had identifiable precipitants.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] source
Not checked in the free run.
- Premisenone given
Required doses of potassium supplementation in TPP are variable and range from 10 to 200 mEq.
“Required doses of potassium supplementation are variable and range from 10 to 200 mEq.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Because TPP does not recur once the patient is euthyroid, adequate control of hyperthyroidism is the mainstay of therapy.
“Because TPP does not recur once the patient's euthyroid adequate control of hyperthyroidism is the mainstay of therapy.”
Quote in the paperSubstantial claim - Premisecitation
At a dose of 40 mg four times a day, propranolol prevented paralysis in carbohydrate-induced TPP in about two thirds of cases by inhibiting the activity of Na/K-ATPase.
“At a dose of 40 mg four times a day, propranolol prevented paralysis in carbohydrate-induced TPP in about two thirds of cases by inhibiting the activity of Na/K-ATPase [46].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] source
Not checked in the free run.
- Premisenone given
Electrocardiographic findings in TPP may be characteristic of hypokalemia, with increased P-wave amplitude, prolonged PR interval, widened QRS complexes, decreased T-wave amplitude, and U waves.
“Electrocardiographic findings may be characteristic of hypokalemia, with increased P-wave amplitude, prolonged PR interval, widened QRS complexes, decreased T-wave amplitude, and U waves.”
Quote in the paperNot a substantial claim - Premisecitation
In a large study by Chang et al. in 2013, 135 patients with TPP were followed up for 10 years.
“In a large study by Chang et al. [24] in 2013 one hundred and thirty five patients of TPP were followed up for 10 years.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] source
Not checked in the free run.
- Premisecitation
High-dose oral propranolol (3-4 mg/kg orally) alone has been reported to rapidly abort the paralysis in TPP.
“High-dose oral propranolol (3-4 mg/kg orally) alone has been reported to rapidly abort the paralysis [45].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] 2001, American Journal of Kidney Diseases source
Not checked in the free run.
- Premisenone given
In severe cases of hypokalemia in TPP, even fatal arrhythmias (sinus arrest, second degree AV block, ventricular fibrillation, and ventricular tachycardia) have been seen.
“In severe cases of hypokalemia, even fatal, arrhythmias (sinus arrest, second degree atrioventricular [AV] block, ventricular fibrillation, and ventricular tachycardia) have been seen.”
Quote in the paperNot a substantial claim - Premisereasoning
There is a positive correlation between the dose of potassium chloride administered and the degree of rebound hyperkalemia.
“There is a positive correlation between the dose of potassium chloride administered and the degree of rebound hyperkalemia.”
Quote in the paperSubstantial claim - Premisenone given
Unlike hypokalemia from other causes, sinus tachycardia predominates in patients with TPP.
“Unlike hypokalemia from other causes, sinus tachycardia predominates in patients with TPP.”
Quote in the paperNot a substantial claim - Premisecitation
In a retrospective case series, patients who received intravenous potassium recovered more quickly than those who received oral supplementation.
“In a retrospective case series, patients who received intravenous potassium recovered more quickly than those who received oral supplementation [43].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] source
Not checked in the free run.
- Premisenone given
Serum phosphate level returns to normal without supplementation when the patient recovers from the weakness.
“Serum phosphate level returns to normal without supplementation when the patient recovers from the weakness.”
Quote in the paperNot a substantial claim - Premisecitation
TPP patients with and without known precipitating factors had no significant differences in their clinical and biochemical findings.
“TPP patients with and without known precipitating factors had no significant differences in their clinical and biochemical findings.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] source
Not checked in the free run.
- Premisecitation
There may be a delayed response of a few hours following potassium administration in TPP.
“There may be a delayed response of a few hours following potassium administration [44].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] source
Not checked in the free run.
- Classified as probably not a substantial claim. 36
- May combine two claims. 37
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHyperthyroidism is more common in females, with a female-to-male ratio of 9:1.
“The male to female ratio ranges from 17 : 1 to 70 : 1 despite the fact that hyperthyroidism is more common in females (female-to-male ratio of 9 : 1) [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] 1996, QJM source
Not checked in the free run.
May combine two claims.
Premisenone givenNeurologic examination during an attack of TPP demonstrates weakness, usually affecting proximal more than distal muscles, and the legs more than the arms.
“Neurologic examination during an attack demonstrates weakness, usually affecting proximal more than distal muscles, and the legs more than the arms.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThyrotoxic periodic paralysis (TPP) is a disorder most commonly seen in Asian men.
“Thyrotoxic periodic paralysis (TPP), a disorder most commonly seen in Asian men, is characterized by abrupt onset of hypokalemia and paralysis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] source
Not checked in the free run.
May combine two claims.
InterpretationreasoningIn TPP, reduced outward K+ current because of loss-of-function mutations of Kir2.6 causes a similar imbalance between inward leak current and outward K+ current, and it results in paradoxical depolarization.
“In TPP, reduced outward K+ current because of loss-of-function mutations of Kir2.6 causes a similar imbalance between inward leak current and outward K+ current, and it results in paradoxical depolarization.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenTPP primarily affects the lower extremities and is secondary to thyrotoxicosis.
“The condition primarily affects the lower extremities and is secondary to thyrotoxicosis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe incidence of TPP in Japanese thyrotoxic patients is 1.9%.
“The incidence of TPP in Chinese and Japanese thyrotoxic patients has been reported at 1.8% and 1.9%, respectively [2], whereas in North Americans at 0.1%–0.2% [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] source
Not checked in the free run.
May combine two claims.
Premisenone givenExercise releases potassium from the skeletal muscles, whereas rest promotes influx of potassium.
“Exercise releases potassium from the skeletal muscles, whereas rest promotes influx of potassium.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTPP is characterized by acute onset of severe hypokalemia and profound proximal muscle weakness in patients with thyrotoxicosis.
“TPP is characterized by acute onset of severe hypokalemia and profound proximal muscle weakness in patients with thyrotoxicosis [4].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] 1967, The British Medical Journal
Not checked in the free run.
May combine two claims.
PremisecitationKir2.6 forms functional homotetramer and heterotetramer with Kir2.1.
“Cheng et al. also reported that Kir2.6 forms functional homotetramer and heterotetramer with Kir2.1, another Kir channel in the skeletal muscle.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenAmong hypokalemic periodic paralysis, familial hypokalemic periodic paralysis (FPP) is the most common cause in Western countries, and TPP is the most common cause in Asia.
“Among the hypokalemic periodic paralysis, familial hypokalemic periodic paralysis (FPP) is the most common cause in Western countries, and thyrotoxic periodic paralysis (TPP), characterized by the triad of acute hypokalemia without total body potassium deficit, muscle paralysis, and thyrotoxicosis, is the most common cause in Asia.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe incidence of TPP in Chinese thyrotoxic patients is 1.8%.
“The incidence of TPP in Chinese and Japanese thyrotoxic patients has been reported at 1.8% and 1.9%, respectively [2], whereas in North Americans at 0.1%–0.2% [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe incidence of TPP in North Americans is 0.1%-0.2%.
“The incidence of TPP in Chinese and Japanese thyrotoxic patients has been reported at 1.8% and 1.9%, respectively [2], whereas in North Americans at 0.1%–0.2% [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] 1989, Archives of Internal Medicine source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenPatients with TPP are usually young adult males 20-40 years of age.
“Patients are usually young adult males 20–40 yr of age.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningTestosterone enhances hypertrophy of myoblasts and thus causes higher muscle-to-body mass ratio and total Na+/K+-ATPase abundance in males.
“Testosterone enhances hypertrophy of myoblasts and thus causes higher muscle-to-body mass ratio and total Na+/K+-ATPase abundance in males.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe male to female ratio of TPP ranges from 17:1 to 70:1.
“The male to female ratio ranges from 17 : 1 to 70 : 1 despite the fact that hyperthyroidism is more common in females (female-to-male ratio of 9 : 1) [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] 1996, QJM source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMild myalgia is a complaint in less than half of patients with TPP.
“Mild myalgia is a complaint in less than half of patients [21].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] source
Not checked in the free run.
May combine two claims.
PremisecitationInsulin and catecholamine not only activate Na+/K+ ATPase but also inhibit Kir channels.
“Moreover, insulin and catecholamine not only activate Na+/K+ ATPase but also inhibit Kir channels [17].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn Chinese thyrotoxic patients, TPP occurs in 13% of males and 0.17% of females.
“In the Chinese, TPP occurs in 13% of male and 0.17% of female thyrotoxic patients, in a series published in 1967 [4].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] 1967, The British Medical Journal
Not checked in the free run.
May combine two claims.
PremisecitationHyperinsulinemia is observed in acute attack of TPP, and the release of insulin in response to oral glucose challenge is exaggerated in TPP patients.
“Hyperinsulinemia is also observed in acute attack of TPP, and the release of insulin in response to oral glucose challenge is exaggerated in TPP patients, supporting the idea that insulin participates in the pathogenesis of hypokalemia in TPP [9].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTPP is more commonly reported in oriental Asians.
“Thyrotoxic periodic paralysis (TPP) is more commonly reported in oriental Asians [2].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTPP has also been reported from western countries as a result of migration of different ethnic populations.
“It has also been reported from the western countries as a result of migration of different ethnic populations [3].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] 1992, Medicine source
Not checked in the free run.
May combine two claims.
InterpretationcitationLoss of function of Kir2.6 together with increased activity of Na+/K+ ATPase may trigger a positive feed-forward cycle of hypokalemia, leading to paradoxical depolarization with consequent inactivation of Na+ channel and muscle inexcitability.
“Loss of function of Kir2.6 together with increased activity of Na+/K+ ATPase may trigger a positive feed-forward cycle of hypokalemia, leading to paradoxical depolarization with consequent inactivation of Na+ channel and muscle inexcitability [20].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningTPP is commonly misdiagnosed in Western countries because of its similarities to familial periodic paralysis.
“TPP is commonly misdiagnosed in Western countries because of its similarities to familial periodic paralysis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenIncreased outdoor activity with increased perspiration of potassium and ingestion of sugar-containing cold beverages may be responsible for the higher prevalence of TPP attacks in the summer and fall.
“With respect to the seasonal variation, increased outdoor activity with increased perspiration of potassium and ingestion of sugar-containing cold beverages may be responsible for the higher prevalence of TPP attacks in the summer and fall.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMutations in the gene encoding Kir2.6 are associated with TPP and predispose these patients to acute paralytic attacks.
“Recent studies have shown that mutations in the gene encoding Kir2.6, a skeletal muscle-specific Kir channel, are associated with TPP and predispose these patients to acute paralytic attacks.”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenBiochemical hyperthyroidism with normal urinary potassium excretion and ECG changes are characteristic of TPP.
“Biochemical hyperthyroidism with normal urinary potassium excretion and ECG changes are characteristic of TPP.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenFactors such as high-carbohydrate meal, exercise, steroid, and stress can precipitate an attack of TPP.
“Factors like high-carbohydrate meal exercise, steroid, and stress can precipitate an attack of TPP.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningParalytic attacks occur only during recovery from exercise, and resumption of exercise can abort an attack.
“This explains why paralytic attacks occur only during recovery from exercise and resumption of exercise can abort an attack.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn one series, tachycardia (mean heart rate = 105 bpm) was noted at presentation and distinguished TPP patients from those with familial hypokalemic periodic paralysis.
“In one series, tachycardia (mean heart rate = 105 bpm) was noted at presentation and distinguished these patients from those with familial hypokalemic periodic paralysis [22].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] 2001, QJM source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenA seasonal variation has been suggested for TPP, with more frequent attacks in summer months.
“A seasonal variation has also been suggested, with more frequent attacks in summer months.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenPatients with TPP may experience recurrent episodes of weakness that last from a few hours up to 72 h, with complete recovery in between the attacks.
“Patients may experience recurrent episodes of weakness that last from a few hours up to 72 h, with complete recovery in between the attacks.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPropranolol, but not the selective beta1-blocker metoprolol, also effectively prevented recurrence of paralytic attacks or inhibited paralysis induced by a carbohydrate load.
“Propranolol, but not the selective beta1-blocker metoprolol, also effectively prevented recurrence of paralytic attacks or inhibited paralysis induced by a carbohydrate load.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenTPP has been increasingly documented in Asian and Hispanic populations in the USA.
“TPP has been increasingly documented in Asian and Hispanic populations in the USA.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationUsing Wayne's index, only 17% of TPP patients had toxic thyrotoxicosis (score > 19), supporting the notion that most TPP patients have equivocal symptoms.
“Using the Wayne's index, a reliable quantitative score of hyperthyroid severity, it was found that only 17% of TPP patients had toxic thyrotoxicosis (score > 19), supporting the notion that most TPP patients have equivocal symptoms [24].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationExceptional cases of bulbar weakness and respiratory weakness requiring ventilatory support have been reported in TPP.
“Exceptional cases of bulbar weakness and respiratory weakness requiring ventilatory support have been reported in TPP [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe complication of rhabdomyolysis may occur in a severe attack of TPP.
“The complication of rhabdomyolysis may occur in a severe attack.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.
Interpretationnone givenIncreased awareness among physicians about TPP will result in early diagnosis, appropriate treatment, and the prevention of rebound hyperkalemia.
“Increased awareness among physicians about this disorder will result in early diagnosis, appropriate treatment, and the prevention of rebound hyperkalemia.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenDuring an attack of paralysis or weakness in TPP, serum potassium level is usually less than 3.0 mmol/liter and can be as low as 1.1 mmol/liter.
“During an attack of paralysis or weakness serum, potassium level is usually less than 3.0 mmol/liter and can be as low as 1.1 mmol/liter.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNonspecific beta-adrenergic blockers like propranolol have been proposed as an alternative treatment to ameliorate the paralysis without rebound hyperkalemia and raise the serum levels of potassium and phosphate.
“Nonspecific beta-adrenergic blockers like propranolol have also been proposed as an alternative treatment to ameliorate the paralysis without rebound hyperkalemia and raise the serum levels of potassium and phosphate.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn contrast to familial hypokalemic PP, carbonic anhydrase inhibitors have not been shown to be of benefit in thyrotoxic PP and may even increase the frequency of attacks.
“In contrast to familial hypokalemic PP, carbonic anhydrase inhibitors have not been shown to be of benefit in thyrotoxic PP and may even increase the frequency of attacks [47].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenTraditionally, patients with TPP are given intravenous or oral potassium to hasten muscle recovery and prevent cardiopulmonary complications; however, there is a danger of rebound hyperkalemia due to release of potassium and phosphate from the cells on recovery.
“Traditionally, patients are given intravenous or oral potassium to hasten muscle recovery and prevent cardiopulmonary complications; however, there is a danger of rebound hyperkalemia due to release of potassium and phosphate from the cells on recovery.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenIn addition to hypokalemia, there may be hypophosphatemia and hypomagnesemia in TPP.
“In addition to hypokalemia, there may be hypophosphatemia and hypomagnesemia.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenRebound hyperkalemia occurred in approximately 40% of patients with TPP, especially if they received >90 mEq of potassium chloride within the first 24 hours.
“Rebound hyperkalemia occurred in approximately 40% of patients with TPP, especially if they received >90 mEq of potassium chloride within the first 24 hours.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMost patients with TPP have only mildly elevated serum thyroid hormone levels, and only about 10% may have mild thyrotoxic symptoms.
“Most patients with TPP have only mildly elevated serum thyroid hormone levels and only about 10% of patients may have mild thyrotoxic symptoms [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] 1996, QJM source
Not checked in the free run.
May combine two claims.
PremisecitationAlthough the majority of cases of thyrotoxicosis associated with TPP are due to Graves' disease, TPP can appear with thyrotoxicosis of any origin.
“Although the majority of cases of thyrotoxicosis associated with TPP are due to Graves' disease, TPP can appear with thyrotoxicosis of any origin.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenDecreased muscle tone with hyporeflexia or areflexia is typical in TPP, although normal or hyperactive reflexes may be seen in some cases.
“Decreased muscle tone with hyporeflexia or areflexia is typical, although normal or hyperactive reflexes may be seen in some cases.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenBiochemical hyperthyroidism with normal urinary potassium excretion and ECG changes clinches the diagnosis of TPP.
“Biochemical hyperthyroidism with normal urinary potassium excretion and ECG changes clinches to diagnosis of TPP.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOther electrocardiographic abnormalities in TPP include atrioventricular block, atrial fibrillation, ventricular fibrillation, and asystole.
“Other electrocardiographic abnormalities include atrioventricular block, atrial fibrillation, ventricular fibrillation, and asystole [40, 41].”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenOccasionally, if the patient is at the recovery stage of the paralysis, serum potassium can be normal.
“Occasionally if the patient is at the recovery stage of the paralysis, serum potassium can be normal.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMild to moderate hypophosphatemia in the range of 0.36-0.77 mmol/liter has been reported in two thirds of TPP cases.
“Mild to moderate hypophosphatemia in the range of 0.36–0.77 mmol/liter has been reported in two thirds of cases [39].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39] source
Not checked in the free run.
May combine two claims.
PremisereasoningPrecipitating factors for TPP include high carbohydrate loads, strenuous exercise, trauma, acute URI, high-salt diet, emotional stress, exposure to cold, alcohol ingestion, menstruation, and use of drugs such as corticosteroids, epinephrine, acetazolamide, and nonsteroidal anti-inflammatory drugs.
“Precipitating factors include high carbohydrate loads, strenuous exercise, trauma, acute URI, high-salt diet, emotional stress, exposure to cold, alcohol ingestion, menstruation, and use of drugs such as corticosteroids, epinephrine, acetazolamide, and nonsteroidal anti-inflammatory drugs.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenWorkup for other causes of hypokalemia includes urinary potassium excretion (>30 mEq indicates urinary loss), arterial blood gas for acidosis, and urinary potassium to creatinine ratio, which is <13 in TPP.
“Workup for other causes of hypokalemia include urinary potassium excretion (>30 mEq indicates urinary loss), arterial blood gas for acidosis, urinary potassium to creatinine ratio which is <13 in TPP.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA high carbohydrate or strenuous exercise was identified as precipitant in only 12% and 7% of TPP patients, respectively.
“A high carbohydrate or strenuous exercise was identified as precipitant in only 12 and 7%, respectively.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenThe muscles affected in TPP may be asymmetrical, and bowel and bladder function are never affected.
“The muscles affected may be asymmetrical and bowel and bladder function are never affected.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenSensory function is not affected in TPP.
“Sensory function is not affected.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningAttacks in thyrotoxic PP may be precipitated by events that are associated with an increased release of epinephrine or insulin, both of which cause movement of potassium into cells and low potassium blood levels.
“As with hypokalemic PP, attacks in thyrotoxic PP may be precipitated by events that are associated with an increased release of epinephrine or insulin, both of which cause movement of potassium into cells and low potassium blood levels.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenAlthough attacks of weakness may occur at any time of the day, a high frequency of attacks at night or early in the morning has been reported in TPP.
“Although attacks of weakness may occur at any time of the day, a high frequency of attacks at night or early in the morning has been reported in TPP.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenSerum creatine phosphokinase of muscle origin is elevated in about two thirds of TPP patients, particularly among those whose attacks are precipitated by exercise.
“Serum creatine phosphokinase of muscle origin is elevated in about two thirds of patients, particularly among those whose attacks are precipitated by exercise.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Only a minority (about 2%) of patients with hyperthyroidism develop hypokalemic paralysis.
“only a minority (∼2%) of patients with hyperthyroidism develop hypokalemic paralysis”
The paper relies on this without support.
The resting membrane potential normally hyperpolarizes when extracellular K+ decreases.
“The resting membrane potential should hyperpolarize when extracellular K+ decreases.”
The paper relies on this without support.
Thyroid hormone can stimulate Na+-K+ ATPase in skeletal muscle by genomic and nongenomic mechanisms.
“Thyroid hormone can stimulate Na+-K+ ATPase in skeletal muscle by genomic mechanism, acting on the thyroid hormone responsive elements to upregulate the transcription of the gene encoding Na+/K+ ATPase and via nongenomic mechanisms by enhancing the intrinsic activity or promoting membrane insertion of the pump.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Thyrotoxic hypokalemic periodic paralysis (THPP) is characterized by recurrent episodes of muscle weakness and hypokalemia due to intracellular potassium shifting in the presence of high thyroid hormone.
“Thyrotoxic hypokalemic periodic paralysis (THPP) is a disease characterized by recurrent episodes of muscle weakness due to intracellular potassium shifting in the presence of high levels of thyroid hormone.”
From Thyrotoxic hypokalemic periodic paralysis triggered by dexamethasone administration (2020) · cites this paper as [2]
THPP occurs more commonly among young Asian men with underlying Graves' disease.
“It occurs more commonly amongst young Asian men with underlying Graves' disease.”
From Thyrotoxic hypokalemic periodic paralysis triggered by dexamethasone administration (2020) · cites this paper as [2]
Sensation is typically intact while deep tendon reflexes are markedly decreased or absent in THPP.
“Sensation is typically intact while deep tendon reflexes are markedly decreased or absent (1,2).”
From Thyrotoxic hypokalemic periodic paralysis triggered by dexamethasone administration (2020) · cites this paper as [2]
Cites
Ryan, D. P., Dias da Silva, M. R., Soong, T. W., Fontaine, B., Donaldson, M. R., Kung, A. W. C., Jongjaroenprasert, W., Liang, M. C., Khoo, D. H. C., Cheah, J. S., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.024 · Cited by 311 · cited 1× · see citing works
“[18] showed that the prevalence of Kir2.”
Periodic paralysis complicating thyrotoxicosis in Chinese.
McFadzean, A. J., & Yeung, R. (1967) · BMJ · doi:10.1136/bmj.1.5538.451 · Cited by 303 · cited 2× · see citing works
“TPP is characterized by acute onset of severe hypokalemia and profound proximal muscle weakness in patients with thyrotoxicosis [4].”
Thyrotoxic Periodic Paralysis in the United States Report of 7 Cases and Review of the Literature
OBER, K. P. (1992) · Medicine · doi:10.1097/00005792-199205000-00001 · Cited by 289 · see citing works
Clinical and Metabolic Features of Thyrotoxic Periodic Paralysis in 24 Episodes
Manoukian, M. A., Foote, J. A., & Crapo, L. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.6.601 · Cited by 255 · cited 1× · see citing works
“77mmol/liter has been reported in two thirds of cases [39].”
Lin, S.-H. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.1.99 · Cited by 254 · see citing works
Kelley, D. E. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.11.2597 · Cited by 227 · cited 1× · see citing works
“The etiology of hypokalemic paralysis can be generally classified into two groups: hypokalemic periodic paralysis, due to shift of potassium into the intracellular space without a total potassium deficit; and nonhypokalemic periodic paralysis, due to a large potassium deficit via gastrointestinal…”
THE ASSOCIATION OF PERIODIC PARALYSIS AND HYPERTHYROIDISM IN JAPAN
OKINAKA, S., SHIZUME, K., UNO, S., WATANABE, A., IRIE, M., NOGUCHI, A., KUMA, S., KUMA, K., & ITO, T. (1957) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-17-12-1454 · Cited by 206 · cited 2× · see citing works
“Thyrotoxic periodic paralysis (TPP) is more commonly reported in oriental Asians [2].”
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis
Matthews, E., Labrum, R., Sweeney, M. G., Sud, R., Haworth, A., Chinnery, P. F., Meola, G., Schorge, S., Kullmann, D. M., Davis, M. B., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000342387.65477.46 · Cited by 201 · cited 1× · see citing works
“leading to paradoxical depolarization with consequent inactivation of Na channel and muscle inexcitability [20].”
Sex differences in sympathetic-adrenal medullary reactions induced by different stressors
Frankenhaeuser, M., Dunne, E., & Lundberg, U. (1976) · Psychopharmacology · doi:10.1007/bf00428693 · Cited by 173 · cited 1× · see citing works
“Catecholamines, a strong activator of NaK-ATPase activity, have been found to be released more in males in response to experimental stress [13].”
Lin, S.-H. (2001) · QJM · doi:10.1093/qjmed/94.3.133 · Cited by 173 · cited 1× · see citing works
“In one series, tachycardia (mean heart rate = 105 bpm) was noted at presentation and distinguished these patients from those with familial hypokalemic periodic paralysis [22].”
In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis.
Chan, A., Shinde, R., Chow, C. C., Cockram, C. S., & Swaminathan, R. (1991) · BMJ · doi:10.1136/bmj.303.6810.1096 · Cited by 160 · cited 1× · see citing works
“Hindawi Publishing Corporation Journal of yroid Research Volume 2014, Article ID 649502, 6 pages http://dx.doi.org/10.1155/2014/649502”
InfluentialThyrotoxic periodic paralysis in a Chinese population
Ko, G. T. C., Chow, C. C., Yeung, V. T. F., Chan, H. H. L., LI, J. K. Y., & Cockram, C. S. (1996) · QJM · doi:10.1093/qjmed/89.6.463 · Cited by 160 · cited 2× · see citing works
“Most patients with TPP have only mildly elevated serum thyroid hormone levels and only about 10% of patients may have mild thyrotoxic symptoms [6].”
Thyrotoxic Periodic Paralysis: Report of 10 Cases and Review of Electromyographic Findings
Kelley, D. E. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390110139031 · Cited by 158 · see citing works
Lin, S.-H., & Lin, Y.-F. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.22090 · Cited by 148 · cited 1× · see citing works
“High-dose oral propranolol (3-4mg/kg orally) alone has been reported to rapidly abort the paralysis [45].”
Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis
Lu, K.-C., Hsu, Y.-J., Chiu, J.-S., Hsu, Y.-D., & Lin, S.-H. (2004) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2004.09.016 · Cited by 134 · see citing works
Periodic paralysis and the sodium‐potassium pump
Layzer, R. B. (1982) · Annals of Neurology · doi:10.1002/ana.410110602 · Cited by 122 · cited 1× · see citing works
“Catecholamine can also increase Na/K-ATPase activity in skeletal muscle [8].”
Yeung, R. T. T., & Tse, T. F. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90010-2 · Cited by 115 · see citing works
Chang, C.-C., Cheng, C.-J., Sung, C.-C., Chiueh, T.-S., Lee, C.-H., Chau, T., & Lin, S.-H. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0381 · Cited by 114 · cited 2× · see citing works
“Using theWayne’s index, a reliable quantitative score of hyperthyroid severity, it was found that only 17% of TPP patients had toxic thyrotoxicosis (score > 19), supporting the notion that most TPP patients have equivocal symptoms [24].”
Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K current
Ruff, R. L. (1999) · Neurology · doi:10.1212/wnl.53.7.1556 · Cited by 112 · cited 1× · see citing works
“Hindawi Publishing Corporation Journal of yroid Research Volume 2014, Article ID 649502, 6 pages http://dx.doi.org/10.1155/2014/649502”
InfluentialTassone, H., Moulin, A., & Henderson, S. O. (2004) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2003.05.004 · Cited by 93 · cited 1× · see citing works
“Theremay be a delayed response of a few hours following potassium administration [44].”
Schofl, C., Becker, C., Prank, K., von zur Muhlen, A., & Brabant, G. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370675 · Cited by 83 · see citing works
The familial periodic paralyses and nondystrophic myotonias
Ptáček, L. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00123-5 · Cited by 82 · cited 1× · see citing works
“In contrast to familial hypokalemic PP, carbonic anhydrase inhibitors have not been shown to be of benefit in thyrotoxic PP andmay even increase the frequency of attacks [47].”
Androgens stimulate preoptic area Na+,K+-ATPase activity in male rats
Guerra, M., Rodriguez Del Castillo, A., Battaner, E., & Mas, M. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90568-4 · Cited by 80 · see citing works
Hsieh, M. ‐., Lyu, R. ‐., Chang, W. ‐., Chang, K. ‐., Chen, C. ‐., Chang, H. ‐., Wu, Y. ‐., Chen, S. ‐., & Ro, L. ‐. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02132.x · Cited by 78 · cited 1× · see citing works
“Mildmyalgia is a complaint in less than half of patients [21].”
Chan, A., Shinde, R., Chow, C. C., Cockram, C. S., & Swaminathan, R. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02532.x · Cited by 77 · cited 1× · see citing works
“Hindawi Publishing Corporation Journal of yroid Research Volume 2014, Article ID 649502, 6 pages http://dx.doi.org/10.1155/2014/649502”
InfluentialElectrocardiographic Manifestations in Patients with Thyrotoxic Periodic Paralysis
Hsu, Y.-J., Lin, Y.-F., Chau, T., Lin, S.-H., Liou, J.-T., & Kuo, S.-W. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200309000-00004 · Cited by 70 · cited 1× · see citing works
“Other electrocardiographic abnormalities include atrioventricular block, atrial fibrillation, ventricular fibrillation, and asystole [40, 41].”
Cheng, C.-J., Lin, S.-H., Lo, Y.-F., Yang, S.-S., Hsu, Y.-J., Cannon, S. C., & Huang, C.-L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.249656 · Cited by 65 · cited 1× · see citing works
“[19] found three additional loss-of-function mutations in Kir2.”
Acute Hypercapnic Respiratory Failure due to Thyrotoxic Periodic Paralysis
Liu, Y.-C., Tsai, W.-S., Chau, T., & Lin, S.-H. (2004) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200405000-00025 · Cited by 63 · cited 1× · see citing works
“Exceptional cases of bulbar weakness and respiratory weakness requiring ventilatory support have been reported in TPP [23].”
Kjeldsen, K., Everts, M. E., & Clausen, T. (1986) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00583377 · Cited by 56 · see citing works
Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP)
Soonthornpun, S., Setasuban, W., & Thamprasit, A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03395.x · Cited by 47 · cited 1× · see citing works
“Hyperinsulinemia is also observed in acute attack of TPP, and the release of insulin in response to oral glucose challenge is exaggerated in TPP patients, supporting the idea that insulin participates in the pathogenesis of hypokalemia in TPP [9].”
Cesur, M., Bayram, F., Temel, M. A., Ozkaya, M., Kocer, A., Ertorer, M. E., Koc, F., Kaya, A., & Gullu, S. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03014.x · Cited by 45 · cited 1× · see citing works
“In a retrospective case series, patients who received intravenous potassium recovered more quickly than thosewho received oral supplementation [43].”
Electrocardiographic changes in thyrotoxic periodic paralysis
Ee, B., Med, M., & Cheah, J. S. (1979) · Journal of Electrocardiology · doi:10.1016/s0022-0736(79)80059-x · Cited by 43 · see citing works
Thyrotoxic hypokalemic periodic paralysis: report of four cases and review of the literature (2).
Td, T., & Vannatta, J. B. (1987) · PubMed · Cited by 39 · see citing works
Puwanant, A., & Ruff, R. L. (2010) · Muscle & Nerve · doi:10.1002/mus.21693 · Cited by 32 · cited 1× · see citing works
“Studies have shown that the outward Kir current is decreased in intercostal muscle fibers of both patients with TPP and familial hypokalemic periodic paralysis [16].”
Thyrotropin-Secreting Pituitary Adenoma Presenting as Hypokalemic Periodic Paralysis
Hsu, F.-S., Chen, H., Chen, Y., Tsai, W.-S., Chau, T., & Lin, S. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200301000-00011 · Cited by 30 · cited 1× · see citing works
“[30, 31], ingestion of T4 or T3 [32, 33], inadvertent iodine excess [34], subacute thyroiditis of de Quervain [35], amiodarone therapy [36], radiation thyroiditis withGraves’ disease [37], and nutraceuticals containing tiratricol [38].”
Biering, H., Bauditz, J., Pirlich, M., Lochs, H., & Gerl, H. (2003) · Hormone Research in Paediatrics · doi:10.1159/000070630 · Cited by 28 · cited 3× · see citing works
“Overall, it appears that patients with TPP have an underlying predisposition for activation of Na/K-ATPase activity, either directly by thyroid hormone or indirectly via adrenergic stimulation, insulin, or exercise.”
Electrocardiographic changes in thyrotoxic periodic paralysis
Boccalandro, C., Lopez, L., Boccalandro, F., & Lavis, V. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03431-8 · Cited by 28 · see citing works
Akar, S., Çömlekçi, A., Bırlık, M., Önen, F., Sarı, İ., Gürler, O., Bekiş, R., & Akkoç, N. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.149 · Cited by 25 · see citing works
Tiratricol-Induced Periodic Paralysis: a review of nutraceuticals affecting thyroid function
Cohen-Lehman, J., Charitou, M. M., & Klein, I. L. (2011) · Endocrine Practice · doi:10.4158/ep10137.ra · Cited by 25 · see citing works
Amiodarone-induced Thyrotoxicosis Presenting as Hypokalemic Periodic Paralysis
Laroia, S., Zaw, K., Ganti, A. K., NEWMAN, W., & Akinwande, A. O. (2002) · Southern Medical Journal · doi:10.1097/00007611-200295110-00018 · Cited by 23 · cited 1× · see citing works
“[30, 31], ingestion of T4 or T3 [32, 33], inadvertent iodine excess [34], subacute thyroiditis of de Quervain [35], amiodarone therapy [36], radiation thyroiditis withGraves’ disease [37], and nutraceuticals containing tiratricol [38].”
Chou, H.-K., Tsao, Y., & Lin, S. (2009) · The American Journal of the Medical Sciences · doi:10.1097/01.maj.0000310783.66897.b6 · Cited by 22 · cited 1× · see citing works
“[30, 31], ingestion of T4 or T3 [32, 33], inadvertent iodine excess [34], subacute thyroiditis of de Quervain [35], amiodarone therapy [36], radiation thyroiditis withGraves’ disease [37], and nutraceuticals containing tiratricol [38].”
Thyrotoxic periodic paralysis due to excessive L-thyroxine replacement in a Caucasian man
Hannon, M. J., Behan, L. A., & Agha, A. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009012 · Cited by 22 · cited 1× · see citing works
“[30, 31], ingestion of T4 or T3 [32, 33], inadvertent iodine excess [34], subacute thyroiditis of de Quervain [35], amiodarone therapy [36], radiation thyroiditis withGraves’ disease [37], and nutraceuticals containing tiratricol [38].”
A case of thyrotropin (TSH)-secreting tumor complicated by periodic paralysis.
KISO, Y., Yoshida, K., KAISE, K., KAISE, N., Masuda, T., Ando, N., Kameyama, M., Yamamoto, M., SAKURADA, T., & YOSHINAGA, K. (1990) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.29.399 · Cited by 21 · cited 1× · see citing works
“[30, 31], ingestion of T4 or T3 [32, 33], inadvertent iodine excess [34], subacute thyroiditis of de Quervain [35], amiodarone therapy [36], radiation thyroiditis withGraves’ disease [37], and nutraceuticals containing tiratricol [38].”
Li, W., Changsheng, C., Jiangfang, F., Bin, G., Nanyan, Z., Xiaomiao, L., Deqiang, L., Ying, X., Wensong, Z., & Qiuhe, J. (2010) · Endocrine · doi:10.1007/s12020-010-9396-3 · Cited by 21 · cited 1× · see citing works
“Also in a recent study none of the 51 cases of TPP developed symptoms after glucose loading test [25].”
Jodbasedow and Thyrotoxic Periodic Paralysis
Ober, K. P. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340090121027 · Cited by 21 · cited 1× · see citing works
“[30, 31], ingestion of T4 or T3 [32, 33], inadvertent iodine excess [34], subacute thyroiditis of de Quervain [35], amiodarone therapy [36], radiation thyroiditis withGraves’ disease [37], and nutraceuticals containing tiratricol [38].”
Lee, J. I., Sohn, T. S., Son, H. S., Oh, S. J., Kwon, H., Chang, S. A., Cha, B. Y., Son, H., & Lee, K. W. (2009) · Thyroid · doi:10.1089/thy.2009.0253 · Cited by 20 · see citing works
Toxic Thyroid Adenoma Presenting as Hypokalemic Periodic Paralysis
Tagami, T., Usui, T., Shimatsu, A., & Naruse, M. (2007) · Endocrine Journal · doi:10.1507/endocrj.k07-126 · Cited by 17 · see citing works
Lettsomian Lectures on the Ophthalmoscope and its Application
Walton, H. (1860) · BMJ · doi:10.1136/bmj.s4-1.181.451 · Cited by 14 · see citing works
[Thyrotoxic hypokalemic periodic paralysis: 18 cases with different forms of thyrotoxicosis].
Piraino Neuenschwander, P., Pumarino Carte, H., Bidegain González, F., Jiménez, M. C. D., & Ferreiro Merino, F. (1995) · PubMed · Cited by 13 · see citing works
Autonomously Functioning Thyroid Nodule Associated with Thyrotoxic Periodic Paralysis
Ozaki, H., Mori, K., Nakagawa, Y., Hoshikawa, S., Ito, S., & Yoshida, K. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-017 · Cited by 8 · cited 1× · see citing works
“Patients with TPP have been reported with thyroiditis [26, 27], toxic adenoma [28], toxic nodular goiter [29], TSH-secreting pituitary adenoma”
Cheng, C.-J., Lin, S.-H., Lo, Y.-F., Yang, S.-S., Hsu, Y.-J., Cannon, S. C., & Huang, C.-L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.a111.249656 · Cited by 6 · see citing works
Jodbasedow and thyrotoxic periodic paralysis
Ober, K. P. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.9.1225 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- 1902, Klin Wochenschr (Bed), 39, 538
- 1967, The British Medical Journal, 1, 451
- 1987, Journal of the Oklahoma State Medical Association, 80, 76
- 1995, Revista Clinica Espanola, 195, 294
Cited by
Sorted by citations
De Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883 · see citing works
World Journal of Pharmaceutical Sciences
(2021) · World Journal of Pharmaceutical Sciences · doi:10.54037/wjps · Cited by 246 · see citing works
Thyrotoxic periodic paralysis: a case study and review of the literature
Meseeha, M., Parsamehr, B., Kissell, K., & Attia, M. (2017) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2017.1316906 · Cited by 32 · see citing works
“Treating hyperthyroidism will prevent attacks and may even reverse muscle weakness [7,8].”
BackgroundInfluentialSardar, Z., Waheed, K. A. F., Javed, M. A., Akhtar, F., & Bokhari, S. R. A. (2019) · Cureus · doi:10.7759/cureus.3921 · Cited by 25 · see citing works
Verma, V., Kumar, Y., Kotwal, N., Upreti, V., Kumar, K. V. S. H., Singh, Y. P., & Menon, A. S. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_335_18 · Cited by 21 · see citing works
Li, X., Yao, S., Xiang, Y., Zhang, X., Wu, X., Luo, L., Huang, H., Zhu, M., Wan, H., & Hong, D. (2015) · BMC Neurology · doi:10.1186/s12883-015-0290-8 · Cited by 18 · see citing works
“descent [3,4].”
Naik, S., Talwar, D., Acharya, S., Kumar, S., & Shrivastava, D. (2021) · Cureus · doi:10.7759/cureus.19566 · Cited by 17 · see citing works
“In patients with thyrotoxicosis, HPP is defined by an initial onset of severe hypokalemia and substantial proximal muscle weakness [6].”
BackgroundThyrotoxic Periodic Paralysis—A Misleading Challenge in the Emergency Department
Bilhă, Ş., Mitu, O., Teodoriu, L. C., Haba, M. Ș. C., & Preda, C. (2020) · Diagnostics · doi:10.3390/diagnostics10050316 · Cited by 16 · see citing works
“The risk of rebound hyperkalemia positively correlates with the dose of KCl received by the patient: administering more than 90 mEq KCl within the first 24 h or at a rate of more than 10 mEq/h poses the highest risk [5,24].”
BackgroundInfluentialDoes thyrotoxic periodic paralysis have a genetic predisposition? A case report
Rasheed, E., Seheult, J. N., Gibney, J., & Boran, G. P. (2018) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563218785395 · Cited by 16 · see citing works
“Unlike other forms of thyroid disease which are more common in females, TPP mainly affects males of Asian ethnicity (especially from China and Japan) in the second to fourth decades of life.(1) Although the incidence of hypokalaemic periodic paralysis complicating thyrotoxicosis is much lower in Caucasians (0.”
Thyrotoxic periodic paralysis with ventricular tachycardia
Tsai, I.-H., & Su, Y. (2019) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2019.04.001 · Cited by 15 · see citing works
Affram, K. O., Reddy, T. L., & Osei, K. M. (2018) · American Journal of Case Reports · doi:10.12659/ajcr.911270 · Cited by 13 · see citing works
“5 mEq/mmol) in the setting of hypokalemia is indicative of potassium loss from the gut, or transcellular shift [5,13].”
BackgroundSevere hypokalemic paralysis and rhabdomyolysis occurring after binge eating in a young bodybuilder
Lee, T. W., Bae, E., Hwang, K., Jang, H. N., Park, H. J., Jeon, D., Cho, H. S., Chang, S., & Park, D. J. (2017) · Medicine · doi:10.1097/md.0000000000008251 · Cited by 12 · see citing works
“The 2 most common forms of hypokalemic paralysis are thyrotoxic and familial periodic hypokalemic paralysis.([1]) The pathophysiology of the paralysis remains unclear.”
BackgroundHypokalemic Periodic Paralysis Precipitated by Thyrotoxicosis and Renal Tubular Acidosis
Jackson, I., Addasi, Y., Ahmed, M., Ramadan, B., Kalian, K., Addasi, N., Nayfeh, A., Taylor, J., Bashir, K., & Krajicek, B. J. (2021) · Case Reports in Endocrinology · doi:10.1155/2021/4529009 · Cited by 10 · see citing works
“It is also more frequent in Asian populations with an incidence of approximately 2% in patients with thyrotoxicosis [1].”
Thyrotoxic periodic paralysis presenting in an African-American teenage male: case report
Glass, J. D., & Osipoff, J. N. (2020) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-020-00077-3 · Cited by 10 · see citing works
Thyrotoxic hypokalemic periodic paralysis triggered by dexamethasone administration
Polamaung, W., Kongkit, J., Yimnoi, P., Boonchaya-Anant, P., & Snabboon, T. (2020) · Acta Medica (Hradec Kralove, Czech Republic) · doi:10.14712/18059694.2020.24 · Cited by 9 · see citing works
“Potassium administration during the attacks should be in oral form dividing into small doses with the maximal daily dose of 90 mEq (2).”
BackgroundInfluentialTu, M.-L., Fang, Y., Leu, J., & Tsai, M. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0971-9 · Cited by 9 · see citing works
Aggarwal, A., Wadhwa, R., Pande, A. K., Sahu, M., Kapoor, D., & Khanna, R. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_619_18 · Cited by 9 · see citing works
“[10] Higher muscle-to-body mass ratio because of testosterone leads to higher total amount of Na+/K+-ATPase in men, increasing their susceptibility.[11] In thyrotoxic patients with TPP, there is an increased number and activity of Na+/K+-ATPase pumps in skeletal muscle cell membranes compared to those without attacks,…”
BackgroundMunir, I., Mehmood, T., Islam, K., Soni, L., & McFarlane, S. I. (2020) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-7-7-5 · Cited by 9 · see citing works
“At the same time, efflux of potassium ions cannot take place because of decreased outward Kir current as explained by certain mutations [2,3,4,9,13,14].”
BackgroundInfluentialVanderpump, M. P. J. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch18 · Cited by 9 · see citing works
Hsiao, Y., Fang, Y., Leu, J., & Tsai, M. (2017) · American Journal of Case Reports · doi:10.12659/ajcr.901793 · Cited by 8 · see citing works
“The adrenergic response to increase Na+/K+-ATPase pump activity can explain why males are at a higher risk of TPP despite thyroid disease being more common in females [8].”
Thyrotoxic periodic paralysis in an adolescent male: A case report and literature review
He, L., Lawrence, V., Moore, W. V., & Yan, Y. (2021) · Clinical Case Reports · doi:10.1002/ccr3.3558 · Cited by 8 · see citing works
Periodic paralysis with normokalemia in a patient with hyperthyroidism
Wang, P.-H., Liu, K., Wu, Y., et al. (2018) · Medicine · doi:10.1097/md.0000000000013256 · Cited by 8 · see citing works
“Thyrotoxic periodic paralysis (TPP) is characterized by a sudden onset of hypokalemia and paralysis.([1]) The condition mainly affects the lower extremities and is secondary to thyrotoxicosis.”
BackgroundInfluentialThyrotoxic periodic paralysis: A case report.
Moteri, B. A., & Aslam, M. (2017) · PubMed · Cited by 7 · see citing works
Case report: Hyperthyroid hypokalemic periodic paralysis
Jaishi, P. P., Neupane, S. K., & Neupane, P. K. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103759 · Cited by 8 · see citing works
“In contrast to other types of thyroid disease, which are more common in women, Hyperthyroid Hypokalemic Periodic Paralysis (HHPP) is much more common in men; it is also more common in Asians [4,5].”
BackgroundResultInfluentialNormokalemic Thyrotoxic Periodic Paralysis with Preserved Reflexes- A Unique Case Report
Chakrabarti, S. K. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/11034.5538 · Cited by 7 · see citing works
Thyrotoxic periodic paralysis: a short clinical review
Aggarwal, R., & Chugh, P. K. (2015) · International Journal of Research in Medical Sciences · doi:10.5455/2320-6012.ijrms20150302 · Cited by 7 · see citing works
Karndumri, K., Thewjitcharoen, Y., Chatchomchuan, W., Porramatikul, S., Krittiyawong, S., Wanothayaroj, E., Butadej, S., Nakasatien, S., Rajatanavin, R., & Himathongkam, T. (2020) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2020.100235 · Cited by 6 · see citing works
“Hypokalemia is a cardinal feature of TPP despite increasing reported unusual cases with normal serum potassium levels [15,16].”
BackgroundMuscle paralysis in thyrotoxicosis
Siddiqui, F. A., & Sheikh, A. (2015) · BMJ Case Reports · doi:10.1136/bcr-2014-207945 · Cited by 5 · see citing works
Coexistence of myasthenia gravis with hypokalemic periodic paralysis: a rare presentation
Khan, F. G., & Namran, S. (2019) · BMJ Case Reports · doi:10.1136/bcr-2019-231241 · Cited by 5 · see citing works
Pan, Y., Xie, Q., Zhang, Z., Dai, Y., Lin, L., Quan, M., Guo, X., Shen, M., & Zhao, S. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.07.015 · Cited by 5 · see citing works
Recurrent thyrotoxic periodic paralysis with normokalemia in a 36‐year‐old man: A case report
Hassen, S. S., Ali, M. S., Khan, A. A., Mohammed, A. M., Al-Termanini, M., Mohanadi, D. H. S. H. A., & Zahid, M. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4849 · Cited by 4 · see citing works
Alrashedi, F. S. (2025) · Cureus · doi:10.7759/cureus.98814 · Cited by 4 · see citing works
“…features of TPP, including (1) rapid improvement once adrenergic drive is blunted, for example, after non-selective beta ( β )-blockade; and (2) the well-described risk of rebound hyperkalemia if aggressive potassium replacement is continued while the transcellular gradient is normalizing [25-27].”
Payus, A. O., Liew, S. L., Tiong, N., et al. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-240666 · Cited by 4 · see citing works
(2023) · PubMed Central · doi:10.7759/cureus.46272 · Cited by 4 · see citing works
“Though thyrotoxicosis usually presents with hyperreflexia, TPP usually presents with absent or diminished reflexes [2-4, 6 , 8, 9].”
BackgroundInfluentialThe genetic association between hyperthyroidism and heart failure: a Mendelian randomization study
Liu, J., Wu, G., Li, S., Cheng, L., & Ye, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1344282 · Cited by 4 · see citing works
“(7), is characterized by muscle paralysis, acute hypokalemia, and thyrotoxicosis (8), and can lead to severe arrhythmia or muscle weakness.”
BackgroundA rare case of thyrotoxic periodic paralysis revealing Graves' disease in a young Malian
Dembélé, M. E., Yalcouyé, A., Cissoko, M., Cissé, L., Guinto, C. O., & Landouré, G. (2024) · Clinical Case Reports · doi:10.1002/ccr3.8527 · Cited by 4 · see citing works
Thyrotoxic hypokalemic periodic paralysis
Urbina-Soto, L., Hernández-Martínez, P., Ortiz-Flores, F., & Hernández, J. L. (2018) · QJM · doi:10.1093/qjmed/hcy186 · Cited by 4 · see citing works
Thyrotoxicosis Periodic Paralysis: A Rare Presentation of a Common Disease
Noumani, J. H. A., Falahi, Z. A., Farhan, H., & Alawi, A. M. A. (2022) · Cureus · doi:10.7759/cureus.25551 · Cited by 3 · see citing works
“It occurs more in Asian males in their 30s and mostly during summertime [4-6].”
BackgroundYounis, A. (2018) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.29.1.46 · Cited by 3 · see citing works
Graves’ Disease Presenting with Periodic Paralysis to the Emergency Department
Lan, N. S. R., & Fegan, P. G. (2018) · Case Reports in Endocrinology · doi:10.1155/2018/9763452 · Cited by 3 · see citing works
“The condition typically affects proximal muscles more than distal muscles and lower limb muscles more than upper limb [1, 3].”
BackgroundInfluentialScheive, M., Patel, N., & Saeed, Z. I. (2023) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-22-0358 · Cited by 3 · see citing works
What the internist should know about hereditary muscle channelopathies
Bissay, V., & Malderen, S. C. H. V. (2017) · Acta Clinica Belgica · doi:10.1080/17843286.2017.1396674 · Cited by 3 · see citing works
Wassner, C., & Cheng, S. H. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13108 · Cited by 3 · see citing works
Parálisis periódica hipocalémica tirotóxica
Quiroga, J. E. O., Abarca, L. C., Pérez, B. H. G., Ocampo-Posada, M., & Garcés-Villabón, L. (2022) · Revista Repertorio de Medicina y Cirugía · doi:10.31260/repertmedcir.01217372.1158 · Cited by 2 · see citing works
Lattouf, A., Alhamss, S., Kiani, A. N., Solanki, N. N., & Younes, N. A. (2024) · Cureus · doi:10.7759/cureus.55822 · Cited by 2 · see citing works
“…due to higher sodium-potassium adenosine triphosphatase (Na+/K+-ATPase) pump activity, and the increased pump activity can be explained by the release of catecholamine after exercise, the release of insulin after a rich carbohydrate diet, and the higher muscle-to-body ratio in men [3,9,10].”
BackgroundUnraveling the Clinical Complexity of Thyrotoxic Periodic Paralysis: A Case Report
Renganathan, G., Thangarasu, S., Singh, B., & Brar, S. K. (2024) · Cureus · doi:10.7759/cureus.66195 · Cited by 2 · see citing works
“Muscle weakness primarily affects the lower extremity proximal muscles, but it can progress rapidly to involve the distal muscles and even the respiratory and bulbar muscles, posing a risk of respiratory failure [2,8,9].”
BackgroundGraves’ disease presenting as life‐threatening hypokalaemic periodic paralysis
Joshi, K. K., de Bock, M. I., & Choong, C. S. (2017) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.13827 · Cited by 2 · see citing works
Sierra, M. A., Muñoz-Castañeda, W. R. A., Tolsa, C., Lara, A. E., Medina, R., & Vega, C. (2019) · Revista de Fomento Social · doi:10.24875/rmn.m19000046 · Cited by 2 · see citing works
Thyrotoxic periodic paralysis after urethral dilatation
Alziadat, M., & Ismail, M. (2020) · Avicenna Journal of Medicine · doi:10.4103/ajm.ajm_54_20 · Cited by 2 · see citing works
“Treatment of TPP includes conservative potassium chloride supplementation to prevent cardiac complications without causing rebound hyperkalemia after resolution of the attack and shift of the intracellular potassium extracellularly.[1,3,5]”
BackgroundInfluentialIs thyrotoxic periodic paralysis a disease caused by muscle membrane dysfunction?
Son, Y.-R., Kim, N., Kim, D., & Park, K. S. (2016) · Muscle & Nerve · doi:10.1002/mus.25532 · Cited by 1 · see citing works
“Thyrotoxic periodic paralysis (TPP) is a secondary form of periodic paralysis that arises as a complication of hyperthyroidism, characterized by muscle paralysis and hypokalemia.(1) Although hyperthyroidism is 10 times more frequently diagnosed in women, especially in iodine-depleted communities, TPP is identified pre…”
BackgroundThyrotoxic Periodic Paralysis: An Unusual Cause of Quadriparesis
Kaeley, N., S, S. A. M., Silpa, S., Gangdev, A. M., & Rajta, M. (2022) · Cureus · doi:10.7759/cureus.29355 · Cited by 1 · see citing works
“The underlying hyperthyroidism is subtle in most cases, which causes difficulty in early diagnosis [2].”
BackgroundInfluentialThyrotoxic Hypokalemic Periodic Paralysis: A Case Series from Trinidad, West Indies
Ramdath, M. M., Teelucksingh, J. D., Ramnath, A., Ramcharan, K., Conyette, L., Ramesar, A., King, R., & Teelucksingh, S. (2015) · West Indian Medical Journal · doi:10.7727/wimj.2015.193 · Cited by 1 · see citing works
“Thyrotoxic periodic paralysis has also been noted with thyroiditis, toxic adenoma, toxic nodular goiter, TSH-secreting pituitary adenoma, ingestion of T4 or T3, inadvertent iodine excess, subacute thyroiditis of de Quervain, amiodarone therapy, radiation thyroiditis with Graves’ disease and nutraceuticals containing t…”
Clossey, D. G., Martin, A., Im, D. D., Reisner, A. T., Wittels, K. A., & Wilcox, S. R. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2019.11.021 · Cited by 1 · see citing works
Thyroid Function in 35 Patients with Gitelman Syndrome
Zhou, H., Ren, Y., Lu, C., Li, Y., Tian, H., & Chen, T. (2020) · BioMed Research International · doi:10.1155/2020/7963898 · Cited by 1 · see citing works
Hyperandrogenism and Hypokalemic Thyrotoxic Periodic Paralysis in a North American Adolescent Girl
Gladding, A., Bartoletti, J., Iyer, P., & Dabrowski, E. C. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae083 · Cited by 1 · see citing works
“These episodes are more common in the early morning and can be triggered by carbohydrate-rich meals, strenuous physical activity, medications such as gluco-corticoids, or other physiologic stressors [14, 15].”
BackgroundBilateral Lower Extremity Paralysis in a Caucasian Male Presenting to the Emergency Department
Bao, Y. K., Ganesan, V. C., Rapp, R. J., & Bao, S. S. (2018) · Case Reports in Emergency Medicine · doi:10.1155/2018/5740509 · Cited by 1 · see citing works
“Thyrotoxic periodic paralysis is not a condition of net potassium deficiency; rather it is a condition of transcellular shift of potassium [4, 7].”
InfluentialSudden Unexpected Death in Endocrine Diseases
Wang, Z., Zhang, H., & Chong, W. (2020) · Springer eBooks · doi:10.1007/978-981-15-7002-5_20 · Cited by 1 · see citing works
Retracted: Thyrotoxic Periodic Paralysis: Clinical Challenges
Research, J. O. T. (2021) · Journal of Thyroid Research · doi:10.1155/2021/7814159 · Cited by 1 · see citing works
RetractedSudden weakness due to thyrotoxic periodic paralysis: a case report
Pinzon, R. T., Wijaya, B. M., & Japanto, E. T. (2022) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci005401202207 · Cited by 1 · see citing works
Case 2: Acute Onset of Lower Extremity Weakness in a 16-year-old Korean Boy
Aikara, S., Naganathan, S., & Eapen, S. (2016) · Pediatrics in Review · doi:10.1542/pir.2015-0130
Thyrotoxic hypokalemic periodic paralysis in a Turkish patient presenting with a U wave on ECG
Gezer, E., Yürekli, B. Ş., & Kocabaş, G. Ü. (2016) · HORMONES · doi:10.14310/horm.2002.1688
A Diagnostic Challenge: Acute Flaccid Paralysis
Lussier, D., & Herd, A. M. (2016) · Canadian Journal of Emergency Medicine · doi:10.1017/cem.2016.355
Sudden Weakness in A Young Healthy Man
Rousseau, L. A., Liu, S. W., Bhatia, K., & Miller, E. S. (2016) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2016.07.005
Hypokalemic thyrotoxic periodic paralysis in a young Serbian male
Ristić, P., Dragovic, T., Kikovic, S., Ristić, D., Zdravkovic, M. D., Hinić, S., Durmić, T., & Hajdukovic, Z. (2018) · Vojnosanitetski pregled · doi:10.2298/vsp161130064r
Thyrotoxicosis Associated Channelopathy
Gopal, K. (2018) · Open Access Journal of Endocrinology · doi:10.23880/oaje-16000121
“Transport of the K + ion is modified by the carbohydrate rich meal and thus insulin level, physical activity, adrenergic tone, hormones, drugs, poisons and the mutations in the genes encoding the channels [1].”
InfluentialA case report on thyrotoxic periodic paralysis from Dhaka, Bangladesh
Haque, M., Jahan, N., & Begum, A. (2020) · Advances in Human Biology · doi:10.4103/aihb.aihb_7_20
Thyrotoxic Periodic Paralysis Presenting with Hypokalemia: A Case Report
Aseri, Z. A. A. (2020) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2020.09.001438
“Diarrhea, fever, strenuous activity, a meal rich in carbohydrates, and febrile illness are common precipitating factors [11-14].”
BackgroundSiddamreddy, S., & Dandu, V. (2021) · StatPearls · Cited by 18 · see citing works
Thyrotoxic Periodic Paralysis: A Review and Suggestions for Treatment
Krasnova, S. L., Topilow, A. A., Calissendorff, J., & Falhammar, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-76097-3.00006-5
Chng, C. L. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_2
Ginting, H. K., & Adi, S. (2022) · The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy · doi:10.24871/231202274-81
Paralisia periódica tireotóxica hipocalêmica com arritmia cardíaca: relato de caso
Amaral, A. D. A. F., Quint, B. B., Pontes, P. A. M., & Falcão, T. R. L. (2022) · Health Residencies Journal - HRJ · doi:10.51723/hrj.v3i16.255
Tênis de Campo como projeto social
Bellinazo, R. G., Engers, P. B., & Ilha, P. V. (2022) · Research Society and Development · doi:10.33448/rsd-v11i9.32035
Thyrotoxic Periodic Paralysis: Case Report
Güler, S. (2020) · Open access Journal of Neurology & Neurosurgery · doi:10.19080/oajnn.2020.12.555845
Radionuclide Therapy in Benign Thyroid Diseases: Graves’ Disease
Araz, M., & Özkan, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-97220-2_5
Ginting, H. K., & Adi, S. (2022) · Current Internal Medicine Research and Practice Surabaya Journal · doi:10.20473/cimrj.v3i2.32528
“This condition mainly affects the lower extremities and is secondary to thyrotoxicosis, especially in the hyperthyroid state caused by Grave’s disease (Vijayakumar et al., 2014).”
BackgroundThyrotoxic periodic paralysis associated with Grave disease: An unusual presentation with weakness
Umalkar, G. N., Vhora, R. S., Chavan, G. N., Kantode, V. V., & Wanjari, M. B. (2022) · Medical Science · doi:10.54905/disssi/v26i130/ms513e2549
Thyrotoxic periodic paralysis mimicking hypokalemic periodic paralysis
Chaudhari, D. V., Chauhan, H., & Panchal, M. (2022) · International Journal of Medicine · doi:10.14419/ijm.v10i1.32035
RECCURENT THYROTOXIC HYPOKALEMIC PERIODIC PARALYSIS: LAPORAN KASUS
Suputra, I. G. L. R. D., & Asmara, I. D. P. G. W. (2023) · Jurnal Medika Malahayati · doi:10.33024/jmm.v7i1.9393
“Secara garis besar hipokalemia pada THPP diakibatkan oleh perpindahan kalium dari ekstrasel ke intrasel terutama ke dalam sel-sel otot secara cepat dan masif tanpa disertai penurunan kadar kalium serum total (Vijayakumar et al., 2014) (Lin & Huang, 2012).”
BackgroundA rare complication of a relatively common disease: periodic paralysis caused by thyrotoxicosis
Chanda, A., Mandal, M., Sarkar, S., & Roy, N. (2023) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20231880
Contreras-García, C., Salgado-Gómez, E., & Ochoa-Magdaleno, J. (2023) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.23000014
Wake-up-Tetraparese: Fallbericht aus der zentralen Notaufnahme
Knop, J., Pennings, J., Schütte, M., Klein, M., Hommen, J. A., Schott, M., Dehina, N., Bernhard, M. H., & Michael, M. (2025) · Notfall + Rettungsmedizin · doi:10.1007/s10049-025-01599-0
Grunewald, C. V., Filho, C. A. D. O., Belíssimo, L. M., Marques, B. C., Souza, E. R. D., Furlan, F. R., & Aguena, M. J. B. (2025) · Aracê. · doi:10.56238/arev7n8-133
Hyperthyroid Hypokalemic Periodic Paralysis in a Nepali Male; A Case Report
Tamang, A., Sapkota, P. P., Humagain, S., Dhakal, K., Sachdeva, C., Shah, D., & Lamsal, P. (2025) · Clinical Case Reports · doi:10.1002/ccr3.71023
Thyrotoxic periodic paralysis presenting as acute quadriparesis in a middle-aged male: a case report
Duraikannan, A., Soni, P., Anandhasekar, M., Arora, R., Kaur, M., & Sinha, S. (2025) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20253309
Thyrotoxic Periodic Paralysis: A Rare but Treatable Emergency
Dave, M., Kashyap, D., Sehgal, A., Amera, K., & Gupta, S. (2025) · doi:10.5005/apijcr-11050-0007
Parálisis hipocalémica como manifestación de enfermedad de Graves
Prado, A. F. D. R., López, J. A. G., & Villafaña, F. C. (2015) · Medicina Interna de México
“A Paralyzing Snack”: An Endocrine Cause of Paralysis
Rombolà, F., & Rodolico, M. (2025) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2026.8
- Authors
- Vijayakumar, A., Ashwath, G., & Thimmappa, D.
- Affiliations
- Victoria Hospital (IN)
- Corresponding author
- Vijayakumar, Abhishek
- Venue
- Journal of Thyroid Research
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-6
- ISSN
- 2042-0072 (ISSN-L)
- 2090-8067
- PMC
- PMC3945080
- OpenAlex
- W2058127823
- Semantic Scholar
- 341ccc3ec8aa20c4ee6754499b17593b301374a5
- Cited by
- 88
- References
- 52
- Citations by year
- 2025: 7 · 2024: 5 · 2023: 5 · 2022: 12 · 2021: 8 · 2020: 16 · 2019: 5 · 2018: 12 · 2017: 6 · 2016: 6 · 2015: 6
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2021-03-16)
- Open access
- hybrid
- doi.org
- Locations
- Journal of Thyroid Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Potassium and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- thyrotoxic periodic paralysis, hypokalemia, thyrotoxicosis, hyperthyroidism, Na+/K+-ATPase, potassium supplementation, beta-blockers, genetic mutations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review